Yes. A man can give a woman a yeast infection after having sex with another woman who has one, even though he has no symptoms himself. His penis can carry Candida yeast from one partner to the next. This is indirect transfer, not a true male infection. The risk is real but modest, and it depends on timing, yeast load, and whether the first partner actually has an active infection.
Vaginal yeast infections are usually caused by Candida albicans, a yeast that lives harmlessly on skin and in the gut for most people. When the vaginal environment shifts, the yeast overgrows and produces symptoms: itching, burning, and thick white discharge. The question here is whether a man can act as a bridge between two women. He can, but the mechanics matter, and the odds are lower than most people assume.
The Transfer Mechanism
Candida albicans is a commensal yeast, meaning it colonizes surfaces without causing harm under normal conditions. It survives on skin, in the mouth, in the gut, and in the vagina. On the penis, it does not usually cause symptoms. This is the key point: a man can carry viable yeast cells on his skin or under his foreskin without any itch, rash, or discharge. He is a carrier, not a case.
During sex with an affected woman, yeast cells from her vagina and vulva transfer to his penile skin. The friction of intercourse, plus vaginal secretions, moves a small but real number of organisms onto his shaft, glans, and foreskin. If he has unprotected sex with a second woman within hours to a day or two, some of those cells can still be viable and can be deposited into her vagina.
The second woman does not automatically develop an infection. A yeast infection requires an overgrowth, not just exposure. Her vaginal pH, estrogen levels, immune response, and local microbiome all influence whether a few transferred cells grow into a symptomatic infection. This is why transfer is possible but inconsistent. A man is a plausible vector, not an efficient one.
One level deeper: Candida albicans can form biofilms, communities of yeast cells that adhere to surfaces and resist washing. On skin, this adhesion is weak compared with medical devices, but it still means simple rinsing does not remove every cell. Viable yeast has been recovered from penile skin after contact, which is the biological basis for the concern.
CDC guidance on vaginal candidiasis notes that Candida is commonly present without symptoms, which supports the carrier model rather than the idea that a man must be "infected" to pass yeast along.
How Often This Actually Happens
Recurrent vulvovaginal candidiasis is defined as four or more symptomatic episodes per year. It affects a small minority of women, generally estimated in the single digits as a percentage of those who get yeast infections at all. Most women who get a yeast infection after a new partner or a changed sexual pattern are not part of a two-woman chain. The far more common scenario is her own yeast overgrowing because of antibiotics, hormonal shifts, or a disrupted microbiome.
Among women who have sex with women, studies have found that Candida can be shared between partners. One partner's vaginal yeast can colonize the other's vagina through direct genital contact or shared sex toys. This is well documented in the sexual-health literature and is why clinicians sometimes ask about partner symptoms in recurrent cases. The man in this scenario adds an indirect route to that same sharing.
Quantify the exposure: a symptomatic yeast infection involves a heavy local load of yeast, often described in the range of millions of colony-forming units per milliliter of vaginal fluid. Transfer to a penis during intercourse likely deposits far fewer cells, and survival on dry skin falls over hours. By the time a second encounter happens, the viable dose may be too low to establish colonization. Timing is the strongest predictor.
There is no national surveillance statistic for how often a man transmits yeast between women. No major public-health body tracks this as a reportable event. The best evidence comes from smaller studies of partner concordance and from the known biology of Candida transmission. That is a real limitation, and it is why this article describes mechanisms and ranges rather than exact rates.
Edge Cases That Raise or Lower Risk
Several factors change the odds in concrete ways.
Active, symptomatic infection in the first woman: this is the single biggest factor. A woman with itching and discharge has a much higher yeast load than a woman with asymptomatic colonization. Unprotected intercourse: condoms block most skin-to-skin transfer and sharply reduce the chance of carriage. Short interval between partners: yeast viability on skin falls over hours to a day. Same-day or next-day contact carries more risk than contact a week later. Uncircumcised penis: the foreskin creates a warm, moist environment where yeast survives longer, increasing carriage time. Shared sex toys without cleaning: this is a direct fomite route between women that bypasses the man entirely but produces the same outcome. Antibiotics or high-estrogen contraception in the second woman: these make her vagina more receptive to yeast overgrowth after any exposure.
WHO information on candidiasis frames Candida as an opportunistic organism, which explains why exposure alone rarely causes disease.
A counterintuitive detail: the man's own symptoms are a poor guide. If he develops balanitis, with redness, itching, or a rash under the foreskin, that actually confirms heavy carriage and raises concern. But the absence of any symptom does not mean he is clear. Most carriers are silent, so symptom-based screening misses them.
Common Misconceptions
The most common misconception is that yeast infections are sexually transmitted in the same way as chlamydia or gonorrhea. They are not. Candida is not classified as an STI by major health agencies, and a yeast infection in a woman with no recent partner change is usually not a sign of infidelity. Sexual contact can move yeast, but the organism is already part of many people's normal flora.
A second misconception is that a man must be "treated" to break the cycle. For most couples, treating the symptomatic woman is enough. Guidelines generally reserve male treatment for men who have symptoms or for cases of recurrent infection where a clinician suspects partner carriage. Routine treatment of asymptomatic male partners is not standard, because it exposes him to antifungal drugs without clear benefit.
A third misconception is that a man can carry yeast indefinitely. He cannot in any meaningful clinical sense. Candida does not establish a chronic, transmissible reservoir on the penis the way it can in the vagina. Carriage is transient, measured in hours to days, which is why the timing window between partners matters so much.
A fourth misconception is about the second woman's blame. If she develops a yeast infection after sex with a man who was recently with another woman, the most likely cause is still her own flora shifting. The transfer route exists, but it competes with far more common triggers, including antibiotics, stress, tight clothing, and hormonal changes. Assuming the partner caused it can create conflict without evidence.
Practical Actions and Thresholds
If you are in this situation, here is what the evidence supports.
Treat the symptomatic woman first. A standard course of an over-the-counter antifungal or a prescription from a clinician resolves most uncomplicated infections. Use condoms during the window when partners are changing. This is the most reliable way to cut skin-to-skin yeast transfer. Clean sex toys between partners and between uses. Wash with soap and warm water, or use a dedicated toy cleaner. Wait before switching partners if you suspect an active infection. A gap of several days lowers viable carriage substantially, though no exact safe interval has been established. See a clinician for recurrent infections, defined as four or more per year. Recurrent cases warrant a workup for underlying causes and a discussion of partner management.
Red flags that warrant medical care:
Fever, pelvic pain, or foul-smelling discharge, which suggest something other than simple candidiasis. Symptoms that do not improve after a standard antifungal course. Recurrent infections despite treatment. A male partner with a painful rash or discharge, which may indicate a different infection. New symptoms in either partner after a partner change, which should prompt STI testing, not just yeast treatment.
No major body publishes a specific "safe interval" between partners for yeast. Any number given as a hard threshold would be invented. The honest guidance is that shorter intervals carry more risk and that condoms reduce it.
Why Certainty Is Limited
The evidence base for male-to-female yeast transfer is thin compared with the evidence for direct female-to-female sharing. Most studies of Candida transmission focus on women who have sex with women, because the direct genital contact makes the route easier to study. The man-as-intermediary route is biologically plausible and clinically reported, but it has not been quantified in large trials.
CDC's STI treatment guidelines do not list candidiasis as a sexually transmitted infection requiring partner notification. That is a deliberate position based on the organism's commensal nature. It does not mean transfer is impossible; it means the public-health priority is treating symptoms, not tracing contacts.
What can be concluded with confidence: a man can carry yeast from one woman to another, carriage is transient, symptoms in the man are uncommon, and the second woman's own risk factors often matter more than the exposure itself. What cannot be concluded: an exact transmission rate, a precise viable-carriage window, or a guaranteed prevention threshold. Any source that offers those numbers without citation is filling gaps with guesswork.
The practical takeaway is straightforward. If a woman develops a yeast infection after a partner change, the most useful steps are treating her symptoms, using condoms during transition periods, and seeing a clinician if infections recur. The man is a possible link, not a likely culprit. Treating him routinely without symptoms is not supported, and testing him is not standard practice. Focus on the symptomatic person and on reducing exposure, and most cases resolve without further investigation.